EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Macrophage transplantation rescues RNASET2-deficient leukodystrophy by replacing deficient microglia in a zebrafish model

Holly A Rutherford, Diogo Candeias iD, Christopher J A Duncan iD, Stephen A Renshaw, Noémie Hamilton iD

Proceedings of the National Academy of Sciences · 21.05.2024 · 121 (21)

DOI: 10.1073/pnas.2321496121 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, online erschienen am 16.05.2024. Verfasst von Holly A Rutherford und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infection and Immunity, School of Medicine and Population Health, University of Sheffield, Sheffield S10 2RX, United Kingdom. Hauptthemen laut MEDLINE: Brain, Macrophages, Microglia. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: UKRI | Medical Research Council (MRC), ELA European Leukodystrophy Association, Sir Jules Thorn Charitable Trust (The Sir Jules Thorn Charitable Trust).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

RNASET2-deficient leukodystrophy is a rare infantile white matter disorder mimicking a viral infection and resulting in severe psychomotor impairments. Despite its severity, there is little understanding of cellular mechanisms of pathogenesis and no treatments. Recent research using the rnaset2 mutant zebrafish model has suggested that microglia may be the drivers of the neuropathology, due to their failure to digest apoptotic debris during neurodevelopment. Therefore, we developed a strategy for microglial replacement through transplantation of adult whole kidney marrow–derived macrophages into embryonic hosts. Using live imaging, we revealed that transplant-derived macrophages can engraft within host brains and express microglia-specific markers, suggesting the adoption of a microglial phenotype. Tissue-clearing strategies revealed the persistence of transplanted cells in host brains beyond embryonic stages. We demonstrated that transplanted cells clear apoptotic cells within the brain, as well as rescue overactivation of the antiviral response otherwise seen in mutant larvae. RNA sequencing at the point of peak transplant-derived cell engraftment confirms that transplantation can reduce the brain-wide immune response and particularly, the antiviral response, in rnaset2-deficient brains. Crucially, this reduction in neuroinflammation resulted in behavioral rescue—restoring rnaset2 mutant motor activity to wild-type (WT) levels in embryonic and juvenile stages. Together, these findings demonstrate the role of microglia as the cellular drivers of neuropathology in rnaset2 mutants and that macrophage transplantation is a viable strategy for microglial replacement in the zebrafish. Therefore, microglia-targeted interventions may have therapeutic benefits in RNASET2-deficient leukodystrophy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BrainMacrophagesMicrogliaAnimalsDisease Models, AnimalLeukoencephalopathiesZebrafishZebrafish Proteins

Stichwörter der Autor:innen

leukodystrophymicrogliatransplantationwhite matter diseasezebrafish

Substanzen

Zebrafish Proteins

Autor:innen und Institutionen

  • Department of Infection and Immunity, School of Medicine and Population Health, University of Sheffield, Sheffield S10 2RX, United Kingdom.
  • Bateson Centre, University of Sheffield, Sheffield S10 2TN, United Kingdom.
  • Department of Biology, University of York, York YO10 5DD, United Kingdom.
  • York Biomedical research Institute, University of York, York YO10 5DD, United Kingdom.
  • Immunology and Inflammation Theme, Translational and Clinical Research Institute, Newcastle University, Newcastle NE2 4HH, United Kingdom.
  • Department of Infection and Tropical Medicine, Royal Victoria Infirmary, Newcastle upon Tyne Hospitals National Health Services Foundation Trust, Newcastle NE2 4HH, United Kingdom.

ORCID-Profile: Diogo Candeias, Christopher J A Duncan, Noémie Hamilton

Förderung

  • UKRI | Medical Research Council (MRC)
  • ELA European Leukodystrophy Association
  • Sir Jules Thorn Charitable Trust (The Sir Jules Thorn Charitable Trust)

Zitieren

APA

Rutherford, H. A., Candeias, D., Duncan, C. J. A., Renshaw, S. A., & Hamilton, N. (2024). Macrophage transplantation rescues RNASET2-deficient leukodystrophy by replacing deficient microglia in a zebrafish model. Proceedings of the National Academy of Sciences, 121(21). https://doi.org/10.1073/pnas.2321496121

Vancouver

Rutherford HA, Candeias D, Duncan CJA, Renshaw SA, Hamilton N. Macrophage transplantation rescues RNASET2-deficient leukodystrophy by replacing deficient microglia in a zebrafish model. Proceedings of the National Academy of Sciences. 2024;121(21). doi:10.1073/pnas.2321496121

BibTeX
@article{Rutherford2024,
  author = {Rutherford, Holly A and Candeias, Diogo and Duncan, Christopher J A and Renshaw, Stephen A and Hamilton, Noémie},
  title = {Macrophage transplantation rescues RNASET2-deficient leukodystrophy by replacing deficient microglia in a zebrafish model},
  journal = {Proceedings of the National Academy of Sciences},
  year = {2024},
  volume = {121},
  number = {21},
  doi = {10.1073/pnas.2321496121}
}
Kostenlos starten →